Chitosan coatings deliver antimicrobials from titanium implants: a preliminary study

Area of Science:

• Biomaterials Science
• Infectious Disease Research
• Drug Delivery Systems

Background:

• Implant-associated infections pose a significant clinical challenge.
• Local antimicrobial delivery systems are crucial for preventing acute implant infections.
• Chitosan is a promising biomaterial for drug delivery applications.

Purpose of the Study:

• To evaluate chitosan coatings for local antimicrobial delivery.
• To measure the release kinetics of tetracycline and chlorhexidine from chitosan.
• To assess the in vitro efficacy and cytotoxicity of eluted antimicrobials.

Main Methods:

• Chitosan coatings with tetracycline or chlorhexidine were applied to titanium.
• Antimicrobial release was measured over 7 days.
• Eluates were tested against Actinobacillus actinomycetemcomitans and Staphylococcus epidermidis.
• Cytotoxicity was assessed using human osteoblasts and fibroblasts.
• In vivo tissue response was evaluated in a rat model.

Main Results:

• Chitosan coatings released 89% of tetracycline within 7 days and 100% of chlorhexidine within 2 days.
• Released tetracycline demonstrated significant pathogen inhibition (95%-99.9%) with no observed cytotoxicity.
• Released chlorhexidine showed antimicrobial activity for 1-2 days (56%-99.5% inhibition) but was cytotoxic.
• Antimicrobial-loaded chitosan coatings elicited an acute inflammatory response similar to unloaded coatings.

Conclusions:

• Chitosan coatings show potential for localized antimicrobial delivery, inhibiting bacteria without host cell toxicity, particularly with tetracycline.
• Further research is warranted to explore chitosan's efficacy in preventing implant infections and promoting osseointegration.